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AbstrACt
Objective Generalised anxiety disorder (GAD) is the most 
common anxiety disorder in the general population and 
has been associated with high economic and human 
burden. However, it has been neglected in the health 
services literature. The objective of this study is to assess 
whether GAD leads to hospital admissions using data from 
the European Prospective Investigation of Cancer-Norfolk. 
Other aims include determining whether early-onset or 
late-onset forms of the disorder, episode chronicity and 
frequency, and comorbidity with major depressive disorder 
(MDD) contribute to hospital admissions.
Design Large, population study.
setting UK population-based cohort.
Participants 30 445 British participants were recruited 
through general practice registers in England. Of these, 
20 919 completed a structured psychosocial questionnaire 
used to identify presence of GAD. Anxiety was assessed in 
1996–2000, and health service use was captured between 
1999/2000 and 2009 through record linkage with large, 
administrative health databases. 17 939 participants had 
complete data on covariates.
Main outcome measure Past-year GAD defined 
according to the Diagnostic and Statistical Manual of 
Mental Disorders, fourth edition.
results In this study, there were 2.2% (393/17 939) of 
respondents with GAD. Anxiety was not independently 
associated with hospital admissions (incidence rate ratio 
(IRR)=1.04, 95% CI 0.90 to 1.20) over 9 years. However, 
those whose anxiety was comorbid with depression 
showed a statistically significantly increased risk for 
hospital admissions (IRR=1.23, 95% CI 1.02 to 1.49).
Conclusion People with GAD and MDD comorbidity were 
at an increased risk for hospital admissions. Clinicians 
should consider that meeting criteria for a pure or 
individual disorder at one point in time, such as past-
year GAD, does not necessarily predict deleterious health 
outcomes; rather different forms of the disorder, such as 
comorbid cases, might be of greater importance.
IntrODuCtIOn
Anxiety disorders1 are the most common 
class of psychiatric disorders in the general 
population. The Global Burden of Disease 
study2 estimated that anxiety disorders 
contribute to roughly 26.8 million disabili-
ty-adjusted life-years, and their annual direct 
cost is $42.3 billion.3 Generalised anxiety 
disorder (GAD) is defined by pervasive worry, 
and a number of additional symptoms, such 
as restlessness, muscle tension, and concen-
tration difficulties. It is a prevalent and 
disabling condition in adults and can lead to 
impairment in social and occupational func-
tioning.4 GAD is associated with poor quality 
of life and risk of suicide.5–8 Out of the anxiety 
disorders, this condition has been found to 
be the most impairing5, and has been linked 
to high cortisol levels.9 Although there is 
effective treatment for GAD, a minority of 
those affected receive any treatment.8 This 
is because anxiety disorders are frequently 
under-recognised and mismanaged by clini-
cians in primary care, which is often the first 
point of contact for those with mental health 
problems.10 
Although detection of anxiety in clin-
ical settings is poor11 12 and the presence of 
undiagnosed mental health problems can 
contribute to further emotional distress in 
patients down the line,12 it could be that 
disorders such as GAD represent more than 
just psychological or worry-related symptoms. 
It may be that anxiety symptoms are masking 
underlying poor physical health or could be 
strengths and limitations of this study
 ► We used a large sample of British people recruit-
ed from the general population, and controlled for 
a number of relevant confounders, such as medical 
history and risk behaviours.  
 ► We used a structured, self-reported questionnaire 
to determine whether participants met criteria for 
past-year GAD according to the DSM-IV.
 ► We examined health service use  through record 
linkage with large, administrative health databases.
 ► Respondents were less deprived and healthier than 
individuals living in other regions of England; there-
fore, our results may not be generalisable to people 
living in extremely deprived circumstances.
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an early warning signal for future health problems that 
are not yet detectable by standard medical tests. Such 
problems cannot be simply resolved through psycholog-
ical therapies or psychotropic medication.
Anxiety has been linked to hypothalamic–pituitary–
adrenal axis dysregulation and inflammation, and this 
can lead to poor health.9 A recent study of hospitalised 
patients13 also showed that people with anxiety disor-
ders had more comorbid physical conditions compared 
with people without anxiety disorders. Conversely, 
anxiety could also represent a response to underlying 
medical illness, and physical illness can exacerbate 
anxiety; the possibility of a bidirectional relationship 
between anxiety and physical health should not be 
excluded.14 15 Compelling evidence from prospective 
studies, however, has shown that anxiety can indeed 
increase the risk of serious chronic conditions, such as 
cancer16 and coronary heart disease (CHD).17
When investigating the links between mental disorders 
and health outcomes, early-onset or late-onset forms of 
anxiety disorders, as well as psychiatric comorbidity, should 
be considered. A large study17 of over >1 million Swedish 
men followed for over >20 years showed that early-onset 
forms of mental disorders led to increased risk of incident 
CHD. Anxiety disorders, such as GAD, are also frequently 
comorbid with major depressive disorder (MDD),18 and 
psychiatric comorbidity has been associated with poorer 
quality of life, worse prognosis and higher use of health 
services for mental health problems than pure forms of 
the disorder.19–21 Therefore, identifying clinical aspects, 
such as early-onset or late-onset forms of the condition, 
episode chronicity and frequency, and comorbidity with 
MDD, can lead to better clinical management and insight 
into groups at high risk for health service use.22
GAD is one of the most common anxiety disorders in 
the general population23 and the primary care setting,24 
and has been associated with high economic and human 
burden. However, it has been largely neglected in the 
health services literature, with the exception of some 
studies showing GAD to contribute to higher use of 
primary care services in primary care samples.24–28 Clin-
ical samples, however, have the potential for self-selection 
bias. Further research is needed to determine whether 
GAD leads to hospital admissions.
The objective of this study is to assess the association 
between GAD and hospital admissions in a longitu-
dinal, population cohort of >18 000 British individuals 
followed for 9 years. The aim is also to determine whether 
early-onset or late-onset forms of the disorder, episode 
frequency and chronicity, and comorbidity with MDD 
contribute to health service use.
MethODs
study population
The study population was drawn from the European 
Prospective Investigation of Cancer-Norfolk (EPIC-Nor-
folk), a longitudinal, cohort study.29 30 Between 1993 and 
1997, a total of 30 445 participants over the age of 40, 
living in Norwich and the surrounding towns and rural 
areas were identified through general practice registers 
and recruited. At baseline, respondents were sent a health 
questionnaire, which captured information on sociode-
mographics, medical history, and risk behaviours. Between 
1993 and 1999/2000, participants completed self-re-
ported postal questionnaires provided they remained on 
the study's mailing list, had a valid mailing address, and 
were still alive. Between 1996 and 1999/2000, respon-
dents completed a psychosocial questionnaire, the Health 
and Life Experiences Questionnaire (HLEQ)29, which 
was used to capture information on psychiatric disorders 
and disability. Record linkage with administrative health 
databases using a unique identifier was used to ascertain 
hospital admissions until 2009.
Respondents who completed a baseline health ques-
tionnaire between 1993 and 1997 were eligible for study 
inclusion; those who completed a psychosocial question-
naire between 1996 and 1999/2000 were eligible for 
inclusion in the analysis.
Assessment of GAD
Past-year GAD was defined according to the Diagnostic 
and Statistical Manual of Mental Disorders, fourth 
edition (DSM-IV), and derived using the HLEQ. The 
psychosocial questionnaire captured the onset and offset 
timings of episodes of anxiety disorder.31 Past-year GAD 
consisted of at least one episode that had offset within 
12 months of administration of the HLEQ. DSM-IV GAD 
was identified if respondents endorsed uncontrollable, 
excessive worry for 6 months or longer that contributed 
to life interference and help-seeking. At least three of the 
following symptoms needed to also have been present: 
restlessness, irritability, muscle tension, fatigue, trouble 
concentrating because of worry, mind going blank, 
trouble falling asleep, trouble staying asleep and feeling 
keyed up or on edge.
Assessment of covariates
Potential confounders (based on the literature) included 
sociodemographics (age, sex, education, marital status, 
social class, employment), prevalent physical diseases, 
disability, MDD and risk behaviours (alcohol use, smoking, 
physical activity). The categorisation of the confounders 
included in the models took account of cell size and was 
also done in accordance with previous research.31–37 Age 
was examined as a categorical variable and then divided 
into 10-year bands. Sex was categorised into male versus 
female; marital status was divided into married, single 
(or never married) and others (widowed, divorced, 
separated); educational level into high (vocational or 
formal qualifications at the A-level or O-level or degree-
level qualifications) versus low (no formal qualifica-
tions). The social class variable was created based on the 
Computer-Assisted Standard Occupational Coding37 
and categorised into the following groups: I (profes-
sionals), II (managerial and technical occupations), III 
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non-manual and III manual (skilled workers), IV (partly 
skilled workers) and V (unskilled manual workers). For 
men, social class was assigned based on their own occupa-
tion. Unemployed men were assigned the social class of 
their partner, while retired men were assigned social class 
based on their last emploment. Unemployed men without 
partners were unclassified. Social class for women was 
coded using their partners'. However, if the woman had 
no partner, or the partner's social class was unclassified 
or missing, social class was based on (the woman's) own 
occupation. An unemployed woman without a partner 
was coded as unclassified. The final categorisation of 
social class was manual (skilled manual, partly skilled and 
unskilled) versus non-manual (professionals, managerial 
and technical, and skilled non-manual). Employment was 
categorized into yes versus no.
Behaviour risk factor measures included alcohol intake 
(units of alcohol/week), smoking status (current, former, 
non-smoker) and physical activity (inactive, moderately 
inactive, moderately active, active). Presence of past-year 
MDD (yes/no) defined according to the DSM-IV was also 
examined.38
Individual-level health status measured the presence 
of major prevalent physical diseases associated with 
anxiety ([self] reporting at least one of the following 
physician-diagnosed conditions: asthma, bronchitis, 
allergies, hay fever, stroke, heart attack, cancer, diabetes, 
thyroid conditions, arthritis).39 Disability was measured 
using the physical component summary (PCS) score of 
the Medical Outcomes Study 36-Item Short Form, a valid 
self-assessment instrument. Higher scores correspond to 
better health while lower scores indicate poorer health.40 
The variables described were potential confounders 
and selected based on previous research.41 42
hospital service use
All analyses are based on hospitalisations. Primary care 
service use was not captured in this study.
Frequency of hospitalisation between 1999/2000 
and 2009 was determined using the East Norfolk 
Primary Health Care trust databases, which capture 
publicly funded healthcare activity data and administra-
tive information from facilities, such as hospitals. 
England is under a publicly funded healthcare system 
(the National Health Service), free at the point of 
delivery; therefore, we expect factors, such as access to 
health insurance or personal income, to have a minimal 
impact on the care that is obtained by study participants. 
The databases used in this study are likely to capture most 
hospital admissions from the population, as private sector 
provision is minimal. This means that admissions data in 
our study can be considered complete for the ascertain-
ment of hospital/health service use, and the likelihood 
of bias minimal. To access hospital services in the UK, 
a referral is needed from the primary care practitioner, 
who acts as a gate-keeper to secondary care.
The East Norfolk Primary Health Care databases were 
linked to the EPIC-Norfolk cohort using participants’ 
unique National Health Service numbers, which allow 
complete record linkage across settings and time.
Vital status for participants was determined through 
record linkage with the United Kingdom Office of 
National Statistics. Since vital status was available for all 
respondents, we were able to exclude those who died 
before their health service use was ascertained.
statistical analysis
First, sociodemographics were compared by GAD 
status—Pearson's χ2 test was used to determine whether 
differences were statistically significant for categorical 
variables. Second, the mean number of hospital admis-
sions was determined for each characteristic/covariate—
the Kruskal-Wallis test was used to determine statistical 
significance for categorical covariates with three or more 
categories, while the Wilcoxon rank-sum test was used for 
dichotomous covariates.
The number of hospital admissions was skewed and the 
variance was much larger than the mean. The models 
examining the relation between different forms of GAD 
and hospital service use (number of hospital admis-
sions) were based on zero-inflated negative binomial 
regression. Three models were fitted for hospital admis-
sions with progressive adjustment of confounders: model 
A adjusted for sociodemographics (age, sex, education, 
marital status, social class, employment), physical condi-
tions and disability; model B further accounted for past-
year MDD (assessed at the same time as past-year GAD); 
and model C further controlled for physical activity, 
alcohol and smoking. 
Finally, we determined whether the risk for hospital-
isation was higher among those with (1) ≥3 episodes of 
lifetime GAD (vs those with <3 episodes or no GAD), 
(2) episodes that lasted on average ≥6 months (vs those 
with <6 months or no GAD), (3) age of onset at 30 years 
or younger (vs people with age at onset >30 years or no 
GAD) and (4) psychiatric comorbidity with MDD (vs no 
GAD-MDD comorbidity). Two-sided statistical tests for 
the parameter estimates were conducted, and a P value 
of <0.05 was considered statistically significant. Analyses 
were implemented in SAS V.9.3.
To arrive at the study size, we did the following: of the 
30 445 who completed the baseline HLQ, we retained 
those participants who completed the psychosocial HLEQ 
(20 919), and of these, we kept respondents with complete 
data on covariates (17 939) (figure 1).
Patient involvement
There were no patients involved in the development of 
the research question and outcome measures, the design 
of the study or the recruitment to and conduct of the 
study.
results
Of the 30 445 people who consented to participate in 
EPIC-Norfolk and completed the HLQ at baseline, 20 919 
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participants provided data for the HLEQ; most of the 
missing observations were from past-year GAD (479), 
past-year MDD (700) and disability (1386); the remaining 
missing observations were generated from the other vari-
ables (figure 1). Notable findings from the missing data 
analysis show that people with missing GAD more often 
had pre-existing health conditions, high disability, MDD, 
low alcohol consumption and were without employment 
(online supplementary appendix 1).
The sample used for the analyses consisted of a total of 
17 939 participants. Respondents were assessed between 
1999/2000 and 2009 (figure 1).
In 1996–2000, 393 out of 17 939 (2.2%) people were 
identified as having past-year GAD. Table 1 shows the 
baseline characteristics of participants by GAD status.
Those with GAD were more likely to be younger, 
women, inactive, current smokers, low alcohol consumers, 
of higher educational attainment, single, of non-manual 
social class, without employment, with physical conditions, 
high levels of disability and MDD. Table 2 summarises the 
means and SDs of the number of hospital admissions by 
participant characteristics.
Participants with GAD had a higher frequency of hospi-
talisation compared with those without GAD. Some of the 
findings show that frequency of hospitalisation was mark-
edly higher among older age groups, men, those with low 
educational attainment, unemployed participants, those 
with high levels of disability and with past-year MDD.
Table 3 shows the unadjusted and adjusted incidence 
rate ratios (IRRs) of hospital admissions by GAD status.
After adjustment for sociodemographic variables, phys-
ical conditions and disability, GAD was associated with a 
25% higher incidence rate of hospitalisation (IRR=1.25, 
95% CI 1.09 to 1.43). The IRR was somewhat attenuated 
and became statistically non-significant after further 
adjustment for MDD (IRR=1.10, 95% CI 0.96 to 1.27). 
The effect estimate approached the null after additional 
adjustment for behaviour risk factors (IRR=1.04, 95% CI 
0.90 to 1.20). 
Next, we assessed whether risk for hospital admissions 
varied by frequency of GAD lifetime episodes, anxiety 
episode chronicity, GAD age of onset and whether the 
hospitalisation risk was higher in those with psychiatric 
comorbidity (with MDD) (table 4). Results are based on 
fully adjusted models.
People with >3 lifetime episodes had a somewhat 
higher risk of hospitalisation (IRR=1.07, 95% CI 0.91 to 
1.27). Those whose episodes lasted, on average, 6 months 
or longer also had a slight increased risk for admissions 
compared with those with shorter episodes (IRR=1.07, 
95% CI 0.85 to 1.35). People who developed GAD before 
30 years of age were 16% more likely to be admitted to 
Figure 1 Flow chart of the European Prospective Investigation of Cancer-Norfolk (EPIC-Norfolk) cohort. This is a flow chart 
showing the number of participants at each study stage: the number approached to participate in the EPIC-Norfolk study, the 
number enrolled at baseline who completed the HLQ, those who completed the psychosocial HLEQ, and finally, respondents 
with complete data on covariates. The EPIC-Norfolk study consists of middle-aged and older British people. GAD, generalised 
anxiety disorder; HLEQ, Health and Life Experiences Questionnaire; MDD, major depressive disorder.
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the hospital than those who developed it later in life 
(IRR=1.16, 95% CI 0.95 to 1.41). Finally, we determined 
whether GAD comorbid with MDD is associated with 
hospital admissions. Results showed that people with 
GAD-MDD comorbidity had a 23% higher chance of being 
admitted to hospital than people without comorbidity—
this association was statistically significant (IRR=1.23, 
95% CI 1.02 to 1.49).
DIsCussIOn
This is the first study to assess the association between 
GAD and hospital service use in a population-based 
cohort. This longitudinal study showed that having an 
episode of GAD in the past year was not independently 
associated with hospital admissions during the subse-
quent 9 years. Chronic GAD (at least 6 months), frequent 
GAD (at least three lifetime episodes) and anxiety with 
an early age of onset (before 30 years) did not show statis-
tically significant associations with hospitalisations. In 
contrast, people with GAD and MDD comorbidity were 
at an increased risk of being admitted to hospital than 
those without comorbidity with MDD. The association 
between GAD-MDD comorbidity and hospital admissions 
was statistically significant.
People with past-year GAD were more likely to have 
medical conditions; nonetheless, including these covari-
ates in the model left the association between past-year 
GAD and hospital admissions statistically significant. It 
was only when MDD was introduced in the model as a 
potential confounder that any remaining association with 
hospital service utilisation was explained away.
strengths and limitations
There are several strengths associated with our study. We 
had a large, population-based sample of British adults 
over the age of 40, and took into account rele-
vant confounders. We used a structured questionnaire to 
Table 1 Percentage and number of people with past-year 
generalised anxiety disorder (GAD) reported in 1996–2000 
according to sociodemographic factors, health status 
and behaviour risk factors for the European Prospective 
Investigation of Cancer-Norfolk cohort (n=17 939)
Characteristic
Number with 
characteristic
Percentage and 
number with 
past-year GAD
Sociodemographics
Age (years)
  <50 2359 3.3 (79)***
  50–60 6209 2.9 (179)
  60–70 5733 1.6 (94)
  70+ 3638 1.1 (41)
Sex
  Women 9937 2.5 (249)*
  Men 8002 1.8 (144)
Education†
  Low 6106 2.0 (120)*
  High 11 833 2.3 (273)
Marital status
  Single 686 3.6 (25)***
  Married 14 538 2.0 (284)
  Other‡ 2715 3.1 (84)
Social class
  Manual 6836 2.0 (137)
  Non-manual 11 103 2.3 (256)
Employment
  Yes 7712 2.0 (155)
  No 10 227 2.3 (238)
Health status
Physical conditions§
  Yes 9166 2.7 (251)***
  No 8773 1.6 (142)
Disability level
  High¶ 8900 3.0 (266)***
  Low 9039 1.4 (127)
Psychiatric conditions
Past-year major depressive disorder
  Yes 934 21.4 (200)***
  No 17 005 1.1 (193)
Behaviour risk factors
Physical activity
  Active†† 12 822 2.1 (272)
  Inactive 5117 2.4 (121)
Smoking status
  Current smoker 1893 4.7 (89)***
  Former smoker 7470 1.9 (141)
Continued
Characteristic
Number with 
characteristic
Percentage and 
number with 
past-year GAD
  Never-smoker 8576 1.9 (163)
Alcohol intake
  High‡‡ 9241 2.0 (182)*
  Low 8698 2.4 (211)
*P<0.05, ***P<0.001.
†High education: O-level, A-level, degree; low education: refers to 
no education.
‡Other: divorced, separated, widowed.
§Physical conditions: respiratory disease (asthma and bronchitis), 
allergies and hay fever, stroke, heart attack, cancer, diabetes, 
thyroid conditions, arthritis.
¶Below the physical component summary score value of 50.6.
††Moderately inactive, moderately active, active.
‡‡3+units of alcohol/week (one pint beer=two units, one glass 
wine=one unit, one glass sherry=one unit, one glass spirit=one unit).
Table 1 Continued 
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assess presence of GAD in the past year according to valid 
and reliable criteria, used large administrative health 
databases to examine hospital service use (avoiding the 
self-reporting bias found in questionnaire studies) and 
participants were followed for a long time. Medical histo-
ries were derived according to a large list of self-reported 
physician diagnoses of chronic diseases. Despite this, 
some illnesses may have been missed. It is also possible 
that participants may have underreported certain condi-
tions, which may have introduced measurement error. A 
negligible proportion of respondents may have obtained 
care at private facilities, and thus their health service use 
would not have been recorded for this study. The data-
bases used also did not capture admissions to hospitals 
outside the UK. However, migration in the EPIC-Norfolk 
cohort is minimal and does not present a problem.
Self-evaluated impairment was also included in models 
as a confounder; however, this may have led to overad-
justment in analyses - impairment may be part of the 
expression of psychiatric illness. This may have resulted 
in attenuation of effect estimates. 
Another limitation is that we did not have data on 
primary care service use. Merging population cohorts, 
such as ours, with primary care service administrative 
databases and hospitalisation databases would have 
provided a more complete picture of the burden of GAD 
on the healthcare system.
This study was conducted on people ages 40 years 
and older and may not be generalisable to younger age 
groups. We suspect that the strength of the association 
between GAD-MDD comorbidity and hospital admis-
sions is weaker for younger populations who are typically 
healthier than older people. Although young people 
have a high burden of mental health problems,39 43 they 
Table 2 Hospital admissions (mean, SD) by participant 
characteristics in 17 939 British people between 1999/2000 
and 2009
Characteristic
Total number with 
characteristic
Number 
of admissions 
Mean (SD)
Past-year generalised 
anxiety disorder
  Yes 393 4.0 (6.3)***
  No 17 546 3.4 (13.0)
Sociodemographics
Age (years)
  <50 2359 1.9 (9.8)***
  50–60 6209 3.0 (16.5)
  60–70 5733 3.8 (11.2)
  70+ 3638 4.6 (9.6)
Sex
  Women 9937 3.1 (14.0)***
  Men 8002 3.9 (11.3)
Education†
  Low 6106 4.1 (17.1)***
  High 11 833 3.1 (10.1)
Marital status
  Single 686 3.0 (8.9)***
  Married 14 538 3.3 (10.9)
  Other‡ 2715 4.0 (21.0)
Social class
  Manual 6836 4.0 (18.3)***
  Non-manual 11 103 3.1 (7.8)
Employment
  Yes 7712 2.5 (9.1)***
  No 10 227 4.1 (15.1)
Health status
Physical conditions§
  Yes 9166 3.9 (10.4)***
  No 8773 3.0 (15.1)
Disability level
  High¶ 8900 4.4 (16.5)***
  Low 9039 2.5 (7.8)
Psychiatric conditions
Past-year major 
depressive disorder
  Yes 934 4.5 (13.6)***
  No 17 005 3.4 (12.9)
Behaviour risk factors
Physical activity
  Active†† 12 822 3.2 (13.3)***
  Inactive 5117 4.1 (11.7)
Smoking status
Continued
Characteristic
Total number with 
characteristic
Number 
of admissions 
Mean (SD)
  Current smoker 1893 4.6 (26.8)***
  Former smoker 7470 3.8 (11.4)
  Never-smoker 8576 2.9 (8.6)
Alcohol intake
  High‡‡ 9241 3.2 (13.3)***
  Low 8698 3.7 (12.5)
*P<0.05, ***P<0.001.
†High education: O-level, A-level, degree; low education: refers 
to no education.
‡Other: divorced, separated, widowed.
§Physical conditions: respiratory disease (asthma and 
bronchitis), allergies and hay fever, stroke, heart attack, cancer, 
diabetes, thyroid conditions, arthritis.
¶Below the physical component summary score value of 50.6.
††Moderately inactive, moderately active, active.
‡‡3+units of alcohol/week (one pint beer=two units, one 
glass wine=one unit, one glass sherry=one unit, one glass 
spirit=one unit).
Table 2 Continued 
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Table 3 Associations between past-year generalised anxiety disorder (GAD) reported in 1996–2000 and hospital admissions 
in 1999/2000–2009 in 17 939 British people over the age of 40
Characteristic
IRR and 95% CI
Crude IRR A* B† C‡
Past-year GAD
  Yes 1.18 (1.02 to 1.36) 1.25 (1.09 to 1.43) 1.10 (0.96 to 1.27) 1.04 (0.90 to 1.20)
  No 1.00 1.00 1.00 1.00
Sociodemographics
Age
  Per 10 years 1.36 (1.33 to 1.40) 1.19 (1.16 to 1.23) 1.20 (1.17 to 1.24) 1.21 (1.18 to 1.25)
Sex
  Women 0.80 (0.76 to 0.83) 0.76 (0.73 to 0.79) 0.76 (0.72 to 0.79) 0.78 (0.74 to 0.81)
  Men 1.00 1.00 1.00 1.00
Education§
  Low 1.30 (1.24 to 1.36) 1.13 (1.08 to 1.18) 1.13 (1.08 to 1.19) 1.11 (1.06 to 1.16)
  High 1.00 1.00 1.00 1.00
Marital status
  Single 0.88 (0.79 to 0.99) 0.85 (0.77 to 0.95) 0.85 (0.76 to 0.95) 0.84 (0.76 to 0.94)
  Married 1.00 1.00 1.00 1.00
  Other¶ 1.21 (1.14 to 1.28) 1.17 (1.11 to 1.24) 1.14 (1.07 to 1.21) 1.09 (1.03 to 1.16)
Social class
  Manual 1.29 (1.23 to 1.34) 1.24 (1.19 to 1.30) 1.24 (1.19 to 1.30) 1.21 (1.16 to 1.26)
  Non-manual 1.00 1.00 1.00 1.00
Employment
  Yes 1.00 1.00 1.00 1.00
  No 1.64 (1.57 to 1.71) 1.18 (1.12 to 1.25) 1.18 (1.12 to 1.24) 1.15 (1.09 to 1.21)
Health status
Physical conditions**
  Yes 1.32 (1.26 to 1.37) 1.18 (1.13 to 1.23) 1.17 (1.12 to 1.22) 1.18 (1.13 to 1.23)
  No 1.00 1.00 1.00 1.00
Disability level
  High†† 1.78 (1.71 to 1.86) 1.52 (1.45 to 1.59) 1.51 (1.44 to 1.57) 1.48 (1.42 to 1.55)
  Low 1.00 1.00 1.00 1.00
Psychiatric conditions
Past-year MDD
  Yes 1.34 (1.22 to 1.48) 1.34 (1.22 to 1.48) 1.33 (1.21 to 1.46)
  No 1.00 1.00 1.00
Lifestyle
Physical activity
  Active‡‡ 1.00 1.00
  Inactive 1.27 (1.21 to 1.33) 1.04 (1.00 to 1.09)
Smoking status
  Current smoker 1.60 (1.49 to 1.72) 1.51 (1.41 to 1.62)
  Former smoker 1.33 (1.27 to 1.39) 1.13 (1.08 to 1.18)
  Never-smoker 1.00 1.00
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(especially adolescents) are less likely to have hospitalisa-
tions than older people.44 It could take many years until 
the effects of anxiety comorbid with depression accumu-
late and manifest as poor physical health, thus translating 
into higher use of hospital services. As such, we would 
expect the strength of the association between GAD-MDD 
comorbidity and hospitalisations to be weaker in young 
people; however, future studies should investigate this.
In order to participate in EPIC-Norfolk, participants 
were required to complete extensive health and lifestyle 
questionnaires and undergo regular health examina-
tions. Those who agreed to take part in the study were 
healthier and more affluent than people living in other 
regions of England; as such, findings may not generalise 
to individuals living in extreme deprivation.
Comparison with other studies
Many of the studies assessing the link between psychi-
atric disorders and health service utilisation have focused 
on depression and, to a lesser extent, panic disorder 
and post-traumatic stress disorder (PTSD), while other 
anxiety disorders have been significantly under-re-
searched. Studies on depression as a stand-alone measure 
have shown an association with health service use in both 
clinical and community samples.45 There are substan-
tially fewer studies on anxiety, and a number of these 
have shown positive associations with health service 
use. A US study46 that recruited patients from an outpa-
tient setting showed that anxiety disorders were linked to 
utilisation of outpatient primary and specialty medical 
care services. Patients, however, were recruited from a 
clinical setting located in a predominantly suburban/
rural area, which might have affected generalisability. 
Another study showed anxiety disorders to be associ-
ated with a high number of consultations with general 
and specialty medical providers, such as those working 
in cardiology and dermatology.47 In this study, people 
were sampled from an anxiety clinic, thereby leading to 
possible selection bias. Other studies showed PTSD and 
GAD to be associated with healthcare use; however, this 
research was based on highly select samples that have 
limited generalisability.25 27 48 49 In contrast to the litera-
ture, a major strength of our study was that it was popu-
lation-based. There is also a lack of research assessing 
whether different forms of the disorder contribute to 
even higher health service use rates (comorbid cases are 
typically the most severe, hardest to treat and with the 
poorest prognosis9).
Mechanisms
A more severe course of GAD can lead to higher rates of 
health services, because of unhealthy behaviours, such 
as smoking and alcohol (which we controlled for in our 
analyses). It could also be that a more severe form of 
anxiety, such as GAD-MDD comorbidity, is associated 
with poorer underlying health, which then leads to 
higher health service use rates. Although we adjusted 
for a number of chronic illnesses, it is possible that 
some physician-diagnosed conditions associated with 
GAD-MDD comorbidity and hospitalisations were not 
captured by the HLQ. A third explanation for higher 
health service use in those with comorbid anxiety and 
depression could relate to undiagnosed medical illness 
which is at an early, undetectable stage. Early symptoms 
of disease could be prompting people with psychiatric 
comorbidity to make greater use of health services.
Implications
GAD can increase the risk for disability and impairment.9 
There is insufficient research on its association with health 
services, and the studies that have been conducted are 
small and based on clinical samples. Our study overcomes 
Characteristic
IRR and 95% CI
Crude IRR A* B† C‡
Alcohol intake
  High§§ 0.88 (0.85 to 0.92) 0.92 (0.88 to 0.96)
  Low 1.00 1.00
*Model A: adjusted for sociodemographics (age, sex, education, marital status, social class, employment), physical 
conditions, disability.
†Model B: adjusted for sociodemographics, physical conditions, disability, MDD.
‡Model C: adjusted for sociodemographics, physical conditions, disability, MDD, physical activity, smoking, alcohol.
§High education: O-level, A-level, degree; low education: refers to no education.
¶Other: divorced, separated, widowed.
**Physical conditions: respiratory disease (asthma and bronchitis), allergies and hay fever, stroke, heart attack, 
cancer, diabetes, thyroid conditions, arthritis.
††Below the physical component summary score value of 50.6.
‡‡Moderately inactive, moderately active, active.
§§3+units of alcohol/week (one pint beer=two units, one glass wine=one unit, one glass sherry=one unit, one glass 
spirits=one unit).
IRR, incidence rate ratio; MDD, major depressive disorder.
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Table 4 Associations between different forms of generalised anxiety disorder (GAD) reported in 1996–2000 and hospital 
admissions in 1999/2000–2009 in 17 939 British people over the age of 40
Characteristic IRR and 95% CI
GAD type
Frequent GAD
  Yes* 1.07 (0.91 to 1.27)†
  No 1.00
Chronic GAD
  Yes‡ 1.07 (0.85 to 1.35)†
  No 1.00
Early age GAD onset
  Yes§ 1.16 (0.95 to 1.41)†
  No 1.00
Comorbid GAD 1.23 (1.02 to 1.49)†
  Yes¶ 1.00
  No
Sociodemographics
Age
  Per 10 years 1.22 (1.18 to 1.25) 1.21 (1.18 to 1.25) 1.22 (1.18 to 1.25) 1.21 (1.17 to 1.25)
Sex
  Women 0.78 (0.74 to 0.81) 0.78 (0.74 to 0.81) 0.78 (0.74 to 0.81) 0.78 (0.75 to 0.82)
  Men 1.00 1.00 1.00 1.00
Education**
  Low 1.10 (1.06 to 1.16) 1.11 (1.06 to 1.16) 1.10 (1.06 to 1.16) 1.12 (1.07 to 1.18)
  High 1.00 1.00 1.00 1.00
Marital status
  Single 0.84 (0.76 to 0.94) 0.84 (0.76 to 0.94) 0.84 (0.76 to 0.94) 0.83 (0.74 to 0.93)
  Married 1.00 1.00 1.00 1.00
  Other†† 1.10 (1.03 to 1.16) 1.09 (1.03 to 1.16) 1.09 (1.03 to 1.16) 1.03 (0.97 to 1.10)
Social class
  Manual 1.21 (1.16 to 1.26) 1.21 (1.16 to 1.26) 1.21 (1.16 to 1.26) 1.21 (1.16 to 1.27)
  Non-manual 1.00 1.00 1.00 1.00
Employment
  Yes 1.00 1.00 1.00 1.00
  No 1.15 (1.09 to 1.21) 1.15 (1.09 to 1.21) 1.15 (1.09 to 1.21) 1.17 (1.11 to 1.24)
Health status
Physical conditions‡‡
  Yes 1.17 (1.13 to 1.23) 1.17 (1.13 to 1.23) 1.17 (1.13 to 1.23) 1.17 (1.12 to 1.22)
  No 1.00 1.00 1.00 1.00
Disability level
  High§§ 1.48 (1.42 to 1.55) 1.48 (1.42 to 1.55) 1.48 (1.42 to 1.55) 1.48 (1.42 to 1.55)
  Low 1.00 1.00 1.00 1.00
Psychiatric conditions
Past-year MDD
  Yes 1.32 (1.20 to 1.45) 1.33 (1.22 to 1.46) 1.33 (1.21 to 1.46) –
  No 1.00 1.00 1.00
Lifestyle
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many limitations of previous literature and clarifies that 
individual episodes of GAD measured at a single point in 
time (eg, in the past year) are not associated with health 
service use. Instead, our analyses show that cases that are 
comorbid with depression can lead to increased use of 
hospital services, after controlling for a range of important 
confounders. In this study, GAD-MDD comorbidity was 
associated with a statistically significantly increased risk of 
hospital admissions.
There is insufficient population-based research on 
anxiety, and studies on the association between GAD 
and hospitalisation admissions are lacking. Clinicians 
should consider that it may not necessarily be the diag-
nosis of the individual disorder at one point in time 
(eg, past-year GAD) that is predictive of deleterious 
health outcomes; different forms of the disorder may 
be more important. GAD has a waxing and waning 
course throughout a patient’s life, and many of those 
affected experience relapse after psychiatric treatment 
or develop psychiatric comorbidities.
Our findings are important for clinicians and policy-
makers. A number of people are affected by anxiety–
depression comorbidity.9 As such, clinicians should 
consider more widespread screening for mental health 
problems, and if appropriate, the examination of any 
underlying health conditions that may require treat-
ment in order to prevent future hospital admissions. 
Policymakers should also consider supporting the wide-
spread roll-out of anxiety and depression prevention 
and screening programmes.
Future research, however, needs to examine the 
reasons for the increased hospital service use in those 
with GAD-MDD comorbidity (this can provide additional 
insight into clinical and policy recommendations). To 
provide a better understanding of the links between 
mental and physical health, the bidirectional links 
between anxiety and physical health problems should 
also be examined. Finally, future research should merge 
a population-based cohort with primary and secondary 
care administrative health databases to provide a more 
complete picture of the burden of different forms of 
anxiety on the healthcare system.
COnClusIOn
People with GAD that was comorbid with MDD had 
a higher risk for hospital admissions in the longitu-
dinal EPIC-Norfolk study.
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Characteristic IRR and 95% CI
Physical activity
  Active¶¶ 1.00 1.00 1.00 1.02 (0.97 to 1.07)
  Inactive 1.04 (1.00 to 1.09) 1.04 (1.00 to 1.09) 1.04 (1.00 to 1.09) 1.00
Smoking status
  Current smoker 1.51 (1.41 to 1.62) 1.51 (1.41 to 1.62) 1.51 (1.41 to 1.62) 1.56 (1.45 to 1.68)
  Former smoker 1.13 (1.08 to 1.18) 1.13 (1.08 to 1.18) 1.13 (1.08 to 1.18) 1.14 (1.09 to 1.19)
  Never-smoker 1.00 1.00 1.00 1.00
Alcohol intake
  High*** 0.92 (0.88 to 0.96) 0.92 (0.88 to 0.96) 0.92 (0.88 to 0.96) 0.93 (0.89 to 0.98)
  Low 1.00 1.00 1.00 1.00
*3+ episodes of lifetime GAD.
†Adjusted for sociodemographics, physical conditions, disability, MDD, physical activity, smoking, alcohol.
‡GAD episodes lasted at least 6 months.
§GAD developed before 30 years of age.
¶GAD-MDD comorbidity.
**High education: O-level, A-level, degree; low education: refers to no education.
††Other: divorced, separated, widowed.
‡‡Physical conditions: respiratory disease (asthma and bronchitis), allergies and hay fever, stroke, heart attack, cancer, diabetes, thyroid 
conditions, arthritis.
§§Below the physical component summary score value of 50.6.
¶¶Moderately inactive, moderately active, active.
***3+ units of alcohol/week (one pint beer=two units, one glass wine=one unit, one glass sherry=one unit, one glass spirit=one unit).
IRR, incidence rate ratio; MDD, major depressive disorder.
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